At Biogen, we continuously engage with investigators in an effort to maintain our scientific leadership in a number of therapeutic areas. Below are established areas of research interest for our marketed products and related diseases.
Markers for disease monitoring, disease prognosis and/or risk mitigation
Managing MS-associated symptoms especially on cognitive dysfunction
New or improved quantitative outcome measures in multiple sclerosis, including next generation technology and patient assessment technologies
Multiple disease-modifying therapies including real world/comparative effectiveness, switching and sequencing strategies, and adherence to therapies
MS and its treatment in special populations, i.e. geriatric or pediatric patients, family planning, underrepresented minorities
Studies on the MoA of Biogen products
You are now leaving Biogen’s Medical Research website.
Third party sites
Biogen assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site's endorsement of Biogen or this website.
Thank you for visiting our site.
To proceed please CONTINUE to MARS, Biogen’s online study submission and management portal. If you have any questions please email us at MedicalResearch@biogen.com.